干旱区生态环境知识资源中心(Arid): Cost-Effectiveness of Fondaparinux versus Enoxaparin in Non-st-Elevation Acute Coronary Syndrome in Canada. Oasis-5

Arid

	Cost-Effectiveness of Fondaparinux versus Enoxaparin in Non-st-Elevation Acute Coronary Syndrome in Canada. Oasis-5
	Lozano-Ortega, Greta; Kendall, Robyn; Sculpher, Mark; Terres, Jorge Ross; Robson, Reid; Levy, Adrian
来源期刊	CIRCULATION
ISSN	0009-7322
出版年	2010
卷号	122 期号:21
英文关键词	Acute coronary syndromes Health economics
类型	Meeting Abstract
语种	英语
国家	Canada ; England
收录类别	SCI-E
WOS记录号	WOS:000208231602398
WOS类目	Cardiac & Cardiovascular Systems ; Peripheral Vascular Disease
WOS研究方向	Cardiovascular System & Cardiology
资源类型	期刊论文
条目标识符	http://119.78.100.177/qdio/handle/2XILL650/163686
作者单位	(1)Oxford Outcomes, Vancouver, BC, Canada;(2)Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England;(3)Glaxo SmithKline, Mississauga, ON, Canada;(4)Dalhousie Univ, Halifax, NS, Canada
推荐引用方式 GB/T 7714	Lozano-Ortega, Greta,Kendall, Robyn,Sculpher, Mark,et al. Cost-Effectiveness of Fondaparinux versus Enoxaparin in Non-st-Elevation Acute Coronary Syndrome in Canada. Oasis-5[J],2010,122(21).
APA	Lozano-Ortega, Greta,Kendall, Robyn,Sculpher, Mark,Terres, Jorge Ross,Robson, Reid,&Levy, Adrian.(2010).Cost-Effectiveness of Fondaparinux versus Enoxaparin in Non-st-Elevation Acute Coronary Syndrome in Canada. Oasis-5.CIRCULATION,122(21).
MLA	Lozano-Ortega, Greta,et al."Cost-Effectiveness of Fondaparinux versus Enoxaparin in Non-st-Elevation Acute Coronary Syndrome in Canada. Oasis-5".CIRCULATION 122.21(2010).